Top

Published in:

01-03-2018 | Original Article

Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India

Authors: Nootan Kumar Shukla, S. V Suryanarayana Deo, Pankaj Kumar Garg, N. M. L. Manjunath, Suman Bhaskar, V. Sreenivas

Published in: Indian Journal of Surgical Oncology | Issue 1/2018

Abstract

The aim of the present study was to provide insight into various demographic, clinical, and management profile of Indian patients with oral tongue squamous cell cancer (OTSCC). All the OTSCC patients who had undergone surgical treatment during 1995 to 2010 at a tertiary care center in North India were considered for the present study. The details of the patients were retrieved from a prospectively maintained computerized database. A total of 124 patients were included in the present study. Mean age of the patients was 50.4 ± 12.0 years. Lateral border of the tongue was the most common sub-site involved in 110 (88.7%) patients. Neck nodes were clinically palpable in 56.4% patients. Hemiglossectomy and anterior partial glossectomy were common surgical procedure undertaken in 57.2 and 25.8% patients. Negative resection margin was achieved in 97.5% patients. Pathological neck metastasis was seen in 40.3% patients. Occult neck metastasis was present in 25.9% patients among clinical N0 neck. At a mean follow-up of 29.8 months (SD 3.1), 20.1% developed disease relapse and 4.0% patients developed second primaries. Kaplan-Meier analysis estimated a 5-year disease-free survival of 81.5% and a 5 years overall survival of 78.6%. Cox proportional regression analysis predicted tumor size and number of positive nodes to be independent predictive variables for disease recurrence. Quality controlled surgery, coupled with adjuvant treatment when required, provides a safe and effective treatment of OTSCC with a good disease-free survival and loco-regional control.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013 [cited 2015 Jun 25]. Available from: http://globocan.iarc.fr

Krishnamurthy A, Ramshankar V (2013) Early stage oral tongue cancer among non-tobacco users--an increasing trend observed in a south Indian patient population presenting at a single centre. Asian Pac J Cancer Prev 14:5061–5065CrossRefPubMed

Deo S (2011) Computerized clinical database development in oncology. Indian J Palliat Care 17:S2–S3CrossRefPubMedPubMedCentral

Kobayashi Y, Karasawa K, Komiya Y, Hanyu N, Okamoto M, Chang T-C et al (2007) Therapeutic results for 100 patients with cancer of the mobile tongue treated with low dose rate interstitial irradiation. Anticancer Res 27:1689–1692PubMed

Bhalavat R, Mahantshetty U, Tole S, Jamema S (2009) Treatment outcome with low-dose-rate interstitial brachytherapy in early-stage oral tongue cancers. J Cancer Res Ther 5:192CrossRefPubMed

Thiagarajan S, Nair S, Nair D, Chaturvedi P, Kane SV, Agarwal JP et al (2014) Predictors of prognosis for squamous cell carcinoma of oral tongue. J Surg Oncol 109:639–644CrossRefPubMed

Süslü N, Hoşal AŞ, Aslan T, Sözeri B, Dolgun A (2013) Carcinoma of the oral tongue: a case series analysis of prognostic factors and surgical outcomes. J Oral Maxillofac Surg 71:1283–1290CrossRefPubMed

Fan K-H, Lin C-Y, Kang C-J, Huang S-F, Wang H-M, Chen EY-C et al (2007) Combined-modality treatment for advanced oral tongue squamous cell carcinoma. Int J Radiat Oncol Biol Phys 67:453–461CrossRefPubMed

Chen T-C, Wang C-T, Ko J-Y, Lou P-J, Yang T-L, Ting L-L et al (2010) Postoperative radiotherapy for primary early oral tongue cancer with pathologic N1 neck. Head Neck 32:555–561CrossRefPubMed

10.

Lim YC, Choi EC (2007) Unilateral, clinically T2N0, squamous cell carcinoma of the tongue: surgical outcome analysis. Int J Oral Maxillofac Surg 36:610–614CrossRefPubMed

11.

Mantsopoulos K, Psychogios G, Künzel J, Waldfahrer F, Zenk J, Iro H (2014) Primary surgical therapy for locally limited oral tongue cancer. BioMed Res Int 738716

12.

Ganly I, Patel S, Shah J (2012) Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome. Cancer 118:101–111CrossRefPubMed

13.

Akhtar S, Ikram M, Ghaffar S (2007) Neck involvement in early carcinoma of tongue. Is elective neck dissection warranted? J Pak Med Assoc 57:305–307PubMed

14.

Zhang T, Lubek JE, Salama A, Dyalram D, Liu X, Ord RA (2004) Treatment of cT1N0M0 tongue cancer: outcome and prognostic parameters. J Oral Maxillofac Surg 72:406–414CrossRef

15.

Kokemueller H, Rana M, Rublack J, Eckardt A, Tavassol F, Schumann P et al (2011) The Hannover experience: surgical treatment of tongue cancer--a clinical retrospective evaluation over a 30 years period. Head Neck Oncol 3:27CrossRefPubMedPubMedCentral

16.

Shiga K, Ogawa T, Sagai S, Kato K, Kobayashi T (2007) Management of the patients with early stage oral tongue cancers. Tohoku J Exp Med 212:389–396CrossRefPubMed

17.

Byers RM, El-Naggar AK, Lee YY, Rao B, Fornage B, Terry NH et al (1998) Can we detect or predict the presence of occult nodal metastases in patients with squamous carcinoma of the oral tongue? Head Neck 20:138–144CrossRefPubMed

18.

Yuen AP, Lam KY, Wei WI, Lam KY, Ho CM, Chow TL et al (2000) A comparison of the prognostic significance of tumor diameter, length, width, thickness, area, volume, and clinicopathological features of oral tongue carcinoma. Am J Surg 180:139–143CrossRefPubMed

19.

D’Cruz AK, Vaish R, Kapre N, Dandekar M, Gupta S, Hawaldar R et al (2015) Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med 373:521–529CrossRefPubMed

20.

National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology (NCCN guidelines®). Head and neck cancers, Version 1. 2015. [Internet]. [cited 2015 Jun 27]. Available from: http://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf

21.

Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944CrossRefPubMed

22.

Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB et al (2012) Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the Head & Neck. Int J Radiat Oncol Biol Phys 84:1198–1205CrossRefPubMedPubMedCentral

23.

Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre J-L, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945–1952CrossRefPubMed

24.

Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A et al (2005) Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843–850CrossRefPubMed

25.

Rodrigues PC, Miguel MCC, Bagordakis E, Fonseca FP, de Aquino SN, Santos-Silva AR et al (2014) Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg 43:795–801CrossRefPubMed

26.

Huang S-F, Kang C-J, Lin C-Y, Fan K-H, Yen T-C, Wang H-M et al (2008) Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer 112:1066–1075CrossRefPubMed

27.

Shim SJ, Cha J, Koom WS, Kim GE, Lee CG, Choi EC et al (2010) Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol Lond Engl 5:43CrossRef

28.

Baek C-H, Son Y-I, Jeong H-S, Chung MK, Park K-N, Ko Y-H et al (2008) Intraoral sonography-assisted resection of T1-2 tongue cancer for adequate deep resection. Otolaryngol--Head Neck Surg 139:805–810CrossRefPubMed

29.

Kodama M, Khanal A, Habu M, Iwanaga K, Yoshioka I, Tanaka T et al (2010) Ultrasonography for intraoperative determination of tumor thickness and resection margin in tongue carcinomas. J Oral Maxillofac Surg 68:1746–1752CrossRefPubMed

Title: Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India
Authors: Nootan Kumar Shukla
S. V Suryanarayana Deo
Pankaj Kumar Garg
N. M. L. Manjunath
Suman Bhaskar
V. Sreenivas
Publication date: 01-03-2018
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 1/2018
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-017-0658-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Operable Oral Tongue Squamous Cell Cancer: 15 Years Experience at a Tertiary Care Center in North India

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Recurrent Bleeding Neck Mass: a Case Report

Overt Skeletal Metastases in a Patient of Occult (Microscopic) Follicular Thyroid Carcinoma: a Rare Case

Analysis of Factors Affecting the Longevity of Voice Prosthesis Following Total Laryngectomy with a Review of Literature

Risk Factors for Post-operative Complications in Primary Oral Cancer Surgery—a Prospective Study

A Rare Presentation of Synovial Sarcoma as Cervical Lymphadenopathy in a Pediatric Patient—a Case Report

The Second Victim: Ignored in the Indian Perspective